You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sequential immunization

Showing 1 - 25 of 3,101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells))

Active, not recruiting
  • COVID-19
  • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)
  • Inactivated COVID-19 vaccine (Vero cells)
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Jan 31, 2023

Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial

Recruiting
  • Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
  • Recombinant adenovirus type-5-vectored COVID-19 vaccine
  • Hangzhou, Zhejiang, China
    Xihu District Center for Disease Control and Prevention
May 12, 2022

COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated

Recruiting
  • COVID-19 Pneumonia
  • Coronavirus Infections
  • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)
  • +2 more
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Jan 30, 2023

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine 10µg, Recombinant SARS-CoV-2 Fusion Protein

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
  • +2 more
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Mar 12, 2022

COVID-19 Trial in Hong Kong (BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell), WIBP Omicron Inactivated COVID-19 vaccine

Recruiting
  • COVID-19
  • BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 27, 2022

COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell), COVID-19 vaccine (Vero

Recruiting
  • COVID-19 Pneumonia
  • Coronavirus Infections
  • Recombinant COVID-19 Vaccine (CHO cell)
  • COVID-19 vaccine (Vero cells)
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Dec 27, 2021

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    The Fifth Peoples' Hospital of Zhuhai
Feb 15, 2022

COVID-19 Trial (ABO1009-DP)

Not yet recruiting
  • COVID-19
  • ABO1009-DP
  • (no location specified)
Jul 11, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Nov 14, 2021

COVID-19 Pandemic Trial in Shaoguan (Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine
  • Shaoguan, Guangdong, China
    Shaoguan Hospital of Chinese Medicine
Mar 1, 2022

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),

Recruiting
  • COVID-19
  • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Changde, Hunan, China
  • +2 more
May 30, 2022

Polio, Vaccine Reaction Trial in Hangzhou, Quzhou (vaccinated with Sabin IPV, vaccinated with bOPV)

Completed
  • Polio
  • Vaccine Reaction
  • vaccinated with Sabin IPV
  • vaccinated with bOPV
  • Hangzhou, Zhejiang, China
  • +1 more
Mar 3, 2022

COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Kuching, Sarawak, Malaysia
  • +17 more
Aug 31, 2022

Polio Trial in Hangzhou, Quzhou (Sabin IPV+ bOPV+ bOPV, Sabin IPV + Sabin IPV + bOPV, Sabin IPV + Sabin IPV + Sabin IPV)

Completed
  • Polio
  • Sabin IPV+ bOPV+ bOPV
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 10, 2019

Vaccination, Reaction - Vaccine Trial in Hohhot (Sabin-IPV+bOPV+bOPV, Sabin-IPV+Sabin-IPV+bOPV, Sabin-IPV+Sabin-IPV+Sabin-IPV)

Completed
  • Vaccination
  • Reaction - Vaccine
  • Sabin-IPV+bOPV+bOPV
  • +2 more
  • Hohhot, Inner Mongolia Autonomous Region, China
    Inner Mongolia Autonomous Region Center for Diseases Prevention
Aug 11, 2019

Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)

Enrolling by invitation
  • Corona Virus Disease 2019(COVID-19)
  • 0.3ml of mRNA vaccine
  • Chengdu, China
    West China Second University Hospital
Oct 3, 2022

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Human Papilloma Virus (HPV) Vaccine Trial in Tampa (HPV MISTICS -Provider Level, HPV MISTICS - Parent Level, HPV MISTICS- HPV

Recruiting
  • Human Papilloma Virus (HPV) Vaccine
  • HPV MISTICS -Provider Level
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 9, 2023

Safety, Immunogenicity, Vaccine, COVID-19 Vaccines Trial in Beijing (Vaccine)

Recruiting
  • Safety
  • +4 more
  • Vaccine
  • Beijing, China
  • +2 more
Mar 24, 2022

Malaria Trial in Seattle (PfSPZ Vaccine, PfSPZ Challenge (7G8) for CHMI, Normal Saline)

Completed
  • Malaria
  • PfSPZ Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 15, 2022

Coronavirus Disease 2019 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group)

Completed
  • Coronavirus Disease 2019
  • Recombinant new coronavirus vaccine (CHO cell) group
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Oct 21, 2021

Hepatitis B Trial in New York (Hepatitis B Vaccine (Recombinant))

Not yet recruiting
  • Hepatitis B
  • Hepatitis B Vaccine (Recombinant)
  • New York, New York
    The Rockefeller University
Jun 28, 2022

NSCLC Stage III Trial in Hefei (Envafolimab)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Jun 8, 2022